Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes - Mark, DB; Harrington, RA; Lincoff, AM; Califf, RM; Nelson, CL; Tsiatis, AA (Circulation, 2000)